CAH
Price
$153.71
Change
+$4.75 (+3.19%)
Updated
Sep 26 closing price
Capitalization
36.52B
32 days until earnings call
MCK
Price
$760.55
Change
+$24.03 (+3.26%)
Updated
Sep 26 closing price
Capitalization
94.6B
38 days until earnings call
Interact to see
Advertisement

CAH vs MCK

Header iconCAH vs MCK Comparison
Open Charts CAH vs MCKBanner chart's image
Cardinal Health
Price$153.71
Change+$4.75 (+3.19%)
Volume$1.71M
Capitalization36.52B
McKesson
Price$760.55
Change+$24.03 (+3.26%)
Volume$820.44K
Capitalization94.6B
CAH vs MCK Comparison Chart in %
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. MCK commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and MCK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CAH: $153.71 vs. MCK: $760.55)
Brand notoriety: CAH: Not notable vs. MCK: Notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 72% vs. MCK: 97%
Market capitalization -- CAH: $36.52B vs. MCK: $94.6B
CAH [@Medical Distributors] is valued at $36.52B. MCK’s [@Medical Distributors] market capitalization is $94.6B. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.6B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 1 FA rating(s) are green whileMCK’s FA Score has 4 green FA rating(s).

  • CAH’s FA Score: 1 green, 4 red.
  • MCK’s FA Score: 4 green, 1 red.
According to our system of comparison, MCK is a better buy in the long-term than CAH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 6 TA indicator(s) are bullish while MCK’s TA Score has 6 bullish TA indicator(s).

  • CAH’s TA Score: 6 bullish, 2 bearish.
  • MCK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CAH is a better buy in the short-term than MCK.

Price Growth

CAH (@Medical Distributors) experienced а +2.75% price change this week, while MCK (@Medical Distributors) price change was +8.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.13%. For the same industry, the average monthly price growth was +3.16%, and the average quarterly price growth was +3.38%.

Reported Earning Dates

CAH is expected to report earnings on Oct 30, 2025.

MCK is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical Distributors (+1.13% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($94.6B) has a higher market cap than CAH($36.5B). MCK has higher P/E ratio than CAH: MCK (30.46) vs CAH (23.83). MCK YTD gains are higher at: 33.891 vs. CAH (31.404). MCK has higher annual earnings (EBITDA): 5.19B vs. CAH (3.11B). CAH has more cash in the bank: 3.87B vs. MCK (2.42B). CAH has less debt than MCK: CAH (8.53B) vs MCK (9.93B). MCK has higher revenues than CAH: MCK (378B) vs CAH (223B).
CAHMCKCAH / MCK
Capitalization36.5B94.6B39%
EBITDA3.11B5.19B60%
Gain YTD31.40433.89193%
P/E Ratio23.8330.4678%
Revenue223B378B59%
Total Cash3.87B2.42B160%
Total Debt8.53B9.93B86%
FUNDAMENTALS RATINGS
CAH vs MCK: Fundamental Ratings
CAH
MCK
OUTLOOK RATING
1..100
8393
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
35
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5014
P/E GROWTH RATING
1..100
7817
SEASONALITY SCORE
1..100
5045

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCK's Valuation (30) in the Medical Distributors industry is somewhat better than the same rating for CAH (63). This means that MCK’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Profit vs Risk Rating (3) in the Medical Distributors industry is in the same range as MCK (5). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.

CAH's SMR Rating (99) in the Medical Distributors industry is in the same range as MCK (100). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.

MCK's Price Growth Rating (14) in the Medical Distributors industry is somewhat better than the same rating for CAH (50). This means that MCK’s stock grew somewhat faster than CAH’s over the last 12 months.

MCK's P/E Growth Rating (17) in the Medical Distributors industry is somewhat better than the same rating for CAH (78). This means that MCK’s stock grew somewhat faster than CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHMCK
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
44%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
43%
Momentum
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
60%
MACD
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 11 days ago
64%
Bullish Trend 5 days ago
65%
Declines
ODDS (%)
Bearish Trend 4 days ago
43%
Bearish Trend 11 days ago
39%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
40%
Aroon
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RZC26.100.03
+0.12%
Reinsurance Group of America
VPL87.640.06
+0.07%
Vanguard FTSE Pacific ETF
XCOR77.31N/A
N/A
FundX ETF
LDP21.61-0.15
-0.69%
Cohen & Steers Limited
KEMQ25.92-0.38
-1.43%
KraneShares Em Mkts Cnsmr Tech ETF

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with MCK. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
+3.19%
MCK - CAH
61%
Loosely correlated
+3.26%
COR - CAH
58%
Loosely correlated
+2.74%
HSIC - CAH
14%
Poorly correlated
+0.64%
EDAP - CAH
12%
Poorly correlated
-3.97%
COSM - CAH
11%
Poorly correlated
-0.92%
More

MCK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCK has been closely correlated with COR. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MCK jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCK
1D Price
Change %
MCK100%
+3.26%
COR - MCK
71%
Closely correlated
+2.74%
CAH - MCK
51%
Loosely correlated
+3.19%
HSIC - MCK
15%
Poorly correlated
+0.64%
OMI - MCK
5%
Poorly correlated
-1.45%
ZYXI - MCK
3%
Poorly correlated
-1.36%
More